Shilpa Medicare Limited — Board Meeting, 05-08-2026: Outcome of Board Meeting
05-08-2026 | 01:58 pm
05-08-2026 | 01:58 pm
Shilpa Medicare's board approved Q1 FY27 consolidated results: Revenue from Operations ₹390.01 Cr, Net Profit ₹100.88 Cr, EPS ₹5.16. Subsidiary Shilpa Biocare plans up to EUR 7 million strategic equity partnership in Gate2Brain. Sharath Reddy Kalakota appointed Whole-time Director. FY26 final dividend record date: Sep 4.
No comments yet. Be the first to comment!
